References
- JohannesCBLeTKZhouXJohnstonJADworkinRHThe prevalence of chronic pain in United States adults: results of an Internet-based surveyJ Pain201011111230123920797916
- GaskinDJRichardPThe economic costs of pain in the United StatesJ Pain201213871572422607834
- ChouRFanciulloGJFinePGClinical guidelines for the use of chronic opioid therapy in chronic noncancer painJ Pain200910211313019187889
- DowellDHaegerichTMChouRCDC Guideline for prescribing opioids for chronic pain – United States, 2016MMWR Recomm Rep2016651149
- BenyaminRTrescotAMDattaSOpioid complications and side effectsPain Physician2008112 SupplS105S12018443635
- ManchikantiLDamronKSMcManusCDBarnhillRCPatterns of illicit drug use and opioid abuse in patients with chronic pain at initial evaluation: a prospective, observational studyPain Physician20047443143716858484
- PalmerRECarrellDSCronkiteDThe prevalence of problem opioid use in patients receiving chronic opioid therapy: computer-assisted review of electronic health record clinical notesPain201515671208121425760471
- VowlesKEMcEnteeMLJulnesPSFroheTNeyJPvan der GoesDNRates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesisPain2015156456957625785523
- ChristophTKogelBSchieneKMeenMDeVJFriderichsEBroad analgesic profile of buprenorphine in rodent models of acute and chronic painEur J Pharmacol20055071–3879815659298
- WalshSLPrestonKLBigelowGEStitzerMLAcute administration of buprenorphine in humans: partial agonist and blockade effectsJ Pharmacol Exp Ther199527413613727542336
- KoppertWIhmsenHKorberNDifferent profiles of buprenorphine-induced analgesia and antihyperalgesia in a human pain modelPain20051181–2152216154698
- DavisMPTwelve reasons for considering buprenorphine as a frontline analgesic in the management of painJ Support Oncol201210620921922809652
- SittlRLikarRNautrupBPEquipotent doses of transdermal fentanyl and transdermal buprenorphine in patients with cancer and noncancer pain: results of a retrospective cohort studyClin Ther200527222523715811486
- ZakiPAKeithDEJrBrineGACarrollFIEvansCJLigand-induced changes in surface mu-opioid receptor number: relationship to G protein activation?J Pharmacol Exp Ther200029231127113410688632
- LutfyKCowanABuprenorphine: a unique drug with complex pharmacologyCurr Neuropharmacol20042439540218997874
- Biodelivery Sciences InternationalTechnology platform2016 http://www.bdsi.com/Technology_Platforms.aspxAccessed April 1, 2016
- Belbuca™ (buprenorphine) buccal film, CIII [package insert]Malvern, PAEndo Pharmaceuticals Inc2015
- BaiSAXiangQFinnAEvaluation of the pharmacokinetics of single-and multiple-dose buprenorphine buccal film in healthy volunteersClin Ther201638235836926804639
- RauckRLPottsJXiangQTzanisEFinnAEfficacy and tolerability of buccal buprenorphine in opioid-naive patients with moderate to severe chronic low back painPostgrad Med20161281111
- GimbelJSpieringsELKatzNXiangQTzanisEFinnAEfficacy and tolerability of buccal buprenorphine in opioid-experienced patients with moderate to severe chronic low back pain: results of a phase 3, enriched enrollment, randomized withdrawal studyPain2016157112517252627434505
- WessonDRLingWThe Clinical Opiate Withdrawal Scale (COWS)J Psychoactive Drugs200335225325912924748
- MooreRAMcQuayHJPrevalence of opioid adverse events in chronic non-malignant pain: systematic review of randomised trials of oral opioidsArthritis Res Ther200575R1046R105116207320
- DahanAYassenABijlHComparison of the respiratory effects of intravenous buprenorphine and fentanyl in humans and ratsBr J Anaesth200594682583415833777
- DahanAYassenARombergRBuprenorphine induces ceiling in respiratory depression but not in analgesiaBr J Anaesth200696562763216547090
- PergolizziJAloisiAMDahanACurrent knowledge of buprenorphine and its unique pharmacological profilePain Pract201010542845020492579
- WebsterLGruenerDKirbyTXiangQTzanisEFinnAEvaluation of the tolerability of switching patients on chronic full mu-opioid agonist therapy to buccal buprenorphinePain Med Epub225201610.1093/pm/pnv110
- TompkinsDASmithMTMintzerMZCampbellCMStrainECA double-blind, within subject comparison of spontaneous opioid withdrawal from buprenorphine versus morphineJ Pharmacol Exp Ther2014348221722624227768
- FreyeEAnderson-HillemacherARitzdorfILevyJVOpioid rotation from high-dose morphine to transdermal buprenorphine (Transtec®) in chronic pain patientsPain Pract20077212312917559481
- WolffRFAuneDTruyersCSystematic review of efficacy and safety of buprenorphine versus fentanyl or morphine in patients with chronic moderate to severe painCurr Med Res Opin201228583384522443154